A recent study (Fenhua et al., 2021) showed that the specificity and sensitivity combined pleural effusion IL-33 detection, ADA detection and the peripheral blood T-SPOT test were 100% and 88.5%, respectively. This evidence concerns the gene ADA and Pleural effusion.